Fortitude Biomedicines

Fortitude Biomedicines is a biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) empowered by immunocyte-targeting biologics and molecular glue payloads for the treatment of various autoimmune diseases and cancers. By combining the precise targeting capabilities of ADCs with the catalytic potency of targeted protein degradation, the company is advancing therapies with transformative potential to expand the therapeutic window of ADCs, overcome drug resistance mechanisms, and explore entirely new targets. Fortitude is leveraging the advantages of its GLUE-DAC™ drug discovery platform to drive the development of other pipeline therapies in the fields of oncology and autoimmune diseases.